Show simple item record

dc.contributor.authorGeurten, Rose J
dc.contributor.authorElissen, Arianne M J
dc.contributor.authorBilo, Henk J G
dc.contributor.authorStruijs, Jeroen N
dc.contributor.authorvan Tilburg, Chantal
dc.contributor.authorRuwaard, Dirk
dc.date.accessioned2021-12-23T18:47:44Z
dc.date.available2021-12-23T18:47:44Z
dc.date.issued2021-12-07
dc.identifier.pmid34876422
dc.identifier.doi10.1136/bmjopen-2021-049487
dc.identifier.urihttp://hdl.handle.net/10029/625482
dc.language.isoenen_US
dc.rights© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
dc.subjectepidemiologyen_US
dc.subjectgeneral diabetesen_US
dc.subjecthealth economicsen_US
dc.titleIdentifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures.en_US
dc.typeArticleen_US
dc.identifier.eissn2044-6055
dc.identifier.journalBMJ Open 2021;11(12):e049487en_US
dc.source.journaltitleBMJ open
dc.source.volume11
dc.source.issue12
dc.source.beginpagee049487
dc.source.endpage
dc.source.countryEngland


This item appears in the following Collection(s)

Show simple item record